Brain Cancer
FDA Accepts BLA for Bevacizumab Biosimilar
BY GINA COLUMBUS
Checkpoint Blockade Plus Vaccines Show Synergy in Early GBM Trials
BY BRIELLE BENYON
FDA Approves Bevacizumab Biosimilar for 5 Cancer Types
BY BRIELLE BENYON
Quality of Life Is an Important Endpoint in Cancer Trials
BY GIUSEPPE LOMBARDI, MD, PHD
App for Tracking GBM Symptoms May Fuel Cancer Advancements
BY BRIELLE BENYON
Immunotherapy Combo Falls Short in Brain Cancer Treatment
BY GINA COLUMBUS
It's 'Just the Beginning' of Exciting Brain Cancer News
BY BRIELLE BENYON
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.